Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Copolov

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|December 23, 2011
N-acetylcysteine for major depressive episodes in bipolar disorderPedro V Magalhães, Olívia M Dean, Ashley I Bush, et al.
Acta Neuropsychiatrica|March 9, 2016
Effects of N-acetylcysteine on substance use in bipolar disorder: a randomised placebo-controlled clinical trialMichelle Bernardo, Seetal Dodd, Clarissa S Gama, et al.
Acta Neuropsychiatrica|November 12, 2014
Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trialMichelle Bernardo, Seetal Dodd, Clarissa S Gama, et al.
Biological Psychiatry|June 25, 2002
Paracingulate morphologic differences in males with established schizophrenia: a magnetic resonance imaging morphometric studyMurat Yücel, Geoffrey W Stuart, Paul Maruff, et al.
The Australian and New Zealand Journal of Psychiatry|March 16, 2013
A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomaniaPedro Vieira da Silva Magalhães, Olivia M Dean, Ashley I Bush, et al.
The American Journal of Psychiatry|September 30, 2003
Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophreniaWarrick J Brewer, Stephen J Wood, Patrick D McGorry, et al.
The Journal of Clinical Psychiatry|September 28, 2010
Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophreniaMichael Berk, Ahmed Munib, Olivia Dean, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|December 23, 2011
N-acetylcysteine for major depressive episodes in bipolar disorderPedro V Magalhães, Olívia M Dean, Ashley I Bush, et al.
Acta Neuropsychiatrica|March 9, 2016
Effects of N-acetylcysteine on substance use in bipolar disorder: a randomised placebo-controlled clinical trialMichelle Bernardo, Seetal Dodd, Clarissa S Gama, et al.
Acta Neuropsychiatrica|November 12, 2014
Effects of N-acetylcysteine on substance use in bipolar disorder: A randomised placebo-controlled clinical trialMichelle Bernardo, Seetal Dodd, Clarissa S Gama, et al.
Biological Psychiatry|June 25, 2002
Paracingulate morphologic differences in males with established schizophrenia: a magnetic resonance imaging morphometric studyMurat Yücel, Geoffrey W Stuart, Paul Maruff, et al.
The Australian and New Zealand Journal of Psychiatry|March 16, 2013
A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomaniaPedro Vieira da Silva Magalhães, Olivia M Dean, Ashley I Bush, et al.
The American Journal of Psychiatry|September 30, 2003
Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophreniaWarrick J Brewer, Stephen J Wood, Patrick D McGorry, et al.
The Journal of Clinical Psychiatry|September 28, 2010
Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophreniaMichael Berk, Ahmed Munib, Olivia Dean, et al.
Pageof 3